Quick Answer

If the question is which GLP-1 medication produces the greatest average weight loss, current head-to-head evidence favors tirzepatide over semaglutide in adults with obesity who do not have type 2 diabetes. In the 72-week SURMOUNT-5 trial, participants receiving tirzepatide lost more body weight and reduced their waist circumference more than those receiving semaglutide.

But “best” does not necessarily mean “the medication that produces the largest number on the scale.” The right medication depends on a person's medical history, diabetes status, other medications, side-effect tolerance, treatment goals, and access. Semaglutide and tirzepatide are both established prescription treatments for weight management, and both are used alongside nutrition and physical activity rather than instead of them.

It is also important to distinguish GLP-1 medications from so-called natural GLP-1 supplements. Prescription medicines are specifically designed to activate incretin pathways and can produce substantially larger effects on appetite and body weight than foods or herbal ingredients.

What Is a GLP-1 Medication?

GLP-1 stands for glucagon-like peptide-1, a hormone naturally released by the intestine after eating.

GLP-1 helps coordinate several processes involved in appetite and metabolism. It increases insulin secretion when blood glucose rises, slows gastric emptying, and sends signals involved in fullness and appetite regulation.

GLP-1 receptor agonist medications are designed to mimic some of these effects.

This is why people taking these medications may find that they:

• Feel full sooner

• Experience less hunger

• Think about food less often

• Eat smaller portions

The effect is not simply about “burning more fat.” A major part of the weight-loss response comes from changes in appetite and food intake.

Which GLP-1 Is Best for Weight Loss?

For average weight loss, the strongest current head-to-head evidence points to tirzepatide.

There is an important technical distinction, however. Tirzepatide is not technically a GLP-1-only medication. It activates both the GIP and GLP-1 receptors, which is why it is often described as a dual incretin or GIP/GLP-1 receptor agonist.

Semaglutide, in contrast, is a GLP-1 receptor agonist.

In the 2025 SURMOUNT-5 trial, adults with obesity but without type 2 diabetes were randomly assigned to maximum tolerated doses of tirzepatide or semaglutide for 72 weeks. Tirzepatide produced significantly greater reductions in body weight and waist circumference than semaglutide.

That makes tirzepatide the leading answer if the question is narrowly:

Which of these two medications produced more weight loss in a direct clinical comparison?

The answer is tirzepatide.

That does not mean it is automatically the best choice for every individual.

How Much Weight Can You Lose With a GLP-1?

There is no single number that applies to everyone.

Clinical trials report average weight changes, not guaranteed results for an individual.

Response can be affected by:

• Starting weight

• Dose reached

• Treatment duration

• Diabetes status

• Other medications

• Diet and physical activity

• How consistently treatment is continued

Semaglutide has demonstrated substantial average weight loss in clinical trials, while newer evidence directly comparing the two treatments indicates that tirzepatide can produce greater average weight reduction in adults with obesity without diabetes.

This distinction matters because online discussions sometimes turn trial averages into promises.

A medication can have a high average efficacy while still producing very different results from one person to another.

Is Tirzepatide Better Than Semaglutide?

For weight reduction alone, current direct evidence favors tirzepatide.

The SURMOUNT-5 trial compared maximum tolerated doses of the two medications over 72 weeks and found tirzepatide superior for both body-weight reduction and waist circumference reduction.

But efficacy is only one part of a treatment decision.

Someone with type 2 diabetes, cardiovascular disease, kidney disease, gastrointestinal problems, or other medical considerations may have different priorities when choosing an anti-obesity medication.

The medication with the largest average weight loss is therefore not necessarily the medication a clinician would choose for a particular patient.

What About Semaglutide?

Semaglutide remains one of the most important medications in modern obesity treatment.

At higher doses, semaglutide has demonstrated substantial weight loss and improvements in several obesity-related health measures. NIDDK describes semaglutide as a GLP-1 receptor agonist that reduces hunger and slows digestion, helping decrease appetite and food intake.

Semaglutide is also available under different brand names for different indications.

For example, Wegovy is approved for chronic weight management, while Ozempic is primarily indicated for type 2 diabetes at its approved dosing. The brand name alone therefore does not tell you which treatment is appropriate for weight management.

In March 2026, the FDA also approved a higher 7.2 mg dose of Wegovy for certain adults with obesity or overweight and a related medical condition, adding another option within semaglutide-based weight management.

Why Doesn't the “Strongest” GLP-1 Work for Everyone?

Weight regulation is considerably more complicated than one hormone.

A person's appetite and body weight are influenced by:

• Genetics

• Sleep

• Stress

• Insulin sensitivity

• Muscle mass

• Physical activity

• Food environment

• Other hormones

• Medications

• Existing medical conditions

This explains why two people taking the same medication can experience very different results.

It also explains why treating obesity as simply a matter of willpower misses an important part of the biology.

GLP-1 medications can change appetite signaling, but they work within a much larger metabolic system.

What Happens When You Stop a GLP-1?

This is an important question that is often overlooked when people compare medications.

Obesity is generally treated as a chronic condition, and maintaining weight loss can require ongoing treatment for some people.

Research has found that substantial weight regain can occur after stopping highly effective anti-obesity medications. NIDDK notes that studies of semaglutide found considerable regain after treatment discontinuation, while people who continued treatment maintained or extended their weight loss.

That does not mean everyone will regain all of the weight.

It means that a GLP-1 medication should not automatically be viewed as a short-term “reset.” Before starting treatment, it is worth discussing what long-term weight maintenance might look like.

What About Natural GLP-1 Ingredients?

The popularity of prescription GLP-1 medications has created another category of products marketed as natural GLP-1 boosters.

These products may contain ingredients such as:

• Soluble fiber

• Protein-rich foods

• Berberine

• Green tea compounds

• Curcumin

• Cinnamon

• Fermented foods

These ingredients can support metabolic health and, in some cases, may influence gut hormones or GLP-1-related pathways.

But there is a crucial difference.

They do not reproduce the pharmacological effect of prescription GLP-1 or GIP/GLP-1 medications.

A fiber-rich meal may stimulate the body's normal post-meal GLP-1 response. A prescription medication is designed to produce sustained receptor activation.

This is why claims that an herbal supplement is “just as powerful as Ozempic” should be treated very cautiously.

Can Diet Naturally Increase GLP-1?

Yes. The digestive system naturally releases GLP-1 in response to nutrients.

Meals containing protein, soluble fiber, and healthy fats can support the normal post-meal signals involved in satiety.

For example, a meal containing Greek yogurt, berries, chia seeds, and walnuts provides protein, fiber, and unsaturated fats. Legumes, vegetables, oats, eggs, fish, and minimally processed foods can also contribute to a dietary pattern that supports appetite regulation.

The benefit is broader than GLP-1 alone.

A high-fiber, protein-adequate eating pattern can also support digestion, blood sugar regulation, and preservation of muscle during weight loss.

GLP-1 and Weight Loss After 40

The question becomes particularly relevant during midlife.

Many women notice that weight management feels different during their 40s and 50s. Changes in estrogen, sleep, muscle mass, insulin sensitivity, and activity can all influence body composition.

This does not mean the metabolism suddenly “stops.”

Rather, several small changes can occur simultaneously.

Less muscle can reduce daily energy expenditure. Poor sleep can affect appetite and food choices. Hormonal changes can alter where fat is stored, while insulin resistance may make blood sugar regulation more difficult.

GLP-1-based treatment can address one important part of this system—appetite and metabolic signaling—but it does not replace the need to protect muscle, consume adequate protein, exercise, and address sleep.

Who May Be a Candidate for Prescription Weight-Loss Medication?

Prescription weight-loss medication is generally considered when lifestyle changes alone have not produced sufficient weight loss or when obesity or overweight is accompanied by health risks.

The decision depends on factors such as:

• Body mass index

• Weight-related health conditions

• Previous weight-loss attempts

• Current medications

• Medical history

• Treatment goals

NIDDK emphasizes that weight management should be individualized and that lifestyle changes remain an important part of treatment, whether or not medication is prescribed.

The FDA approved Zepbound (tirzepatide) for chronic weight management in adults with obesity or adults with overweight plus at least one weight-related condition, alongside a reduced-calorie diet and increased physical activity.

See If You Qualify for a GLP-1 Weight-Loss Program →

Eligibility is determined by a licensed healthcare professional. Completing an assessment does not guarantee a prescription or treatment.

Are GLP-1 Medications Safe?

GLP-1-based medications can be appropriate for many people, but they are prescription treatments with potential adverse effects and contraindications.

Gastrointestinal effects such as nausea, vomiting, diarrhea, constipation, or abdominal discomfort are common considerations.

More serious risks are possible, and suitability depends on individual health history.

This is why obtaining these medications through unregulated sources or using them without medical supervision is risky. A clinician can determine whether treatment is appropriate, review other medications, and monitor the response.

So, Which GLP-1 Is Best for Weight Loss?

If maximum average weight loss is the only criterion, current head-to-head evidence gives tirzepatide the advantage over semaglutide in adults with obesity without type 2 diabetes.

But the more useful question is:

Which treatment is most appropriate for your health situation and weight-management goals?

For some people, tirzepatide may be the preferred option because of its greater average weight-loss efficacy. For others, semaglutide may be an appropriate and highly effective choice. And for some people, neither medication will be appropriate.

The decision should take into account the whole metabolic picture rather than focusing exclusively on the largest percentage of weight loss.

Frequently Asked Questions

Which GLP-1 causes the most weight loss?

Among tirzepatide and semaglutide, the strongest direct comparison currently shows greater average weight loss with tirzepatide in adults with obesity without type 2 diabetes.

Is tirzepatide a GLP-1?

Tirzepatide activates both GIP and GLP-1 receptors, so it is more accurately described as a dual GIP/GLP-1 receptor agonist rather than a GLP-1-only medication.

Is Ozempic or Wegovy better for weight loss?

Both contain semaglutide, but they are approved for different indications and dosing schedules. Wegovy is the semaglutide product specifically approved for chronic weight management, while Ozempic is primarily approved for type 2 diabetes. The appropriate treatment depends on the individual's medical situation.

Is Mounjaro or Zepbound better for weight loss?

Both contain tirzepatide. Zepbound is approved for chronic weight management, while Mounjaro is approved for type 2 diabetes. The active ingredient is the same, but the approved indication and labeling differ.

Can you naturally increase GLP-1?

Yes. Eating meals containing soluble fiber, protein, and healthy fats can stimulate the body's normal GLP-1 response. Certain plant compounds and fermented foods are also being studied for their effects on gut hormone pathways.

Are natural GLP-1 supplements as effective as prescription medications?

No. Natural foods and supplements may support GLP-1 release or related metabolic pathways, but they have not been shown to produce the same degree of weight loss as prescription GLP-1 or GIP/GLP-1 medications.

What is the best GLP-1 for women over 40?

There is no single GLP-1 medication that is best for every woman over 40. Age alone does not determine the appropriate treatment. Menopause status, body composition, diabetes risk, cardiovascular health, medications, and other medical factors should be considered.

The Bottom Line

The answer to “Which GLP-1 is best for weight loss?” has become clearer as more head-to-head evidence has emerged.

Tirzepatide currently has the advantage for average weight loss compared with semaglutide in a direct 72-week trial of adults with obesity without type 2 diabetes.

But the best treatment is not necessarily the one with the biggest average number. Weight management is a long-term process, and medication choice should consider effectiveness, tolerability, medical history, other health conditions, and whether the treatment can realistically be maintained.

For people who do not need or do not want prescription medication, the body's natural GLP-1 system can still be supported through a diet rich in protein, soluble fiber, healthy fats, and minimally processed foods. These approaches will not mimic prescription GLP-1 medications, but they can form an important foundation for healthier appetite regulation and metabolic health.

Could you qualify for a GLP-1 weight-loss program?
Find out whether prescription weight-management treatment may be appropriate for you through a confidential online health assessment.

Check Your Eligibility →

A licensed healthcare professional will determine whether treatment is appropriate.

References: U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); U.S. Food and Drug Administration (FDA); New England Journal of Medicine; clinical obesity research.